Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 755,000 | 473,000 | 214,000 | 837,170 | 596,000 |
| Depreciation Amortization | 0 | 0 | 0 | 315,960 | 0 |
| Other Working Capital | -108,000 | -111,000 | -38,000 | 17,860 | -18,000 |
| Other Operating Activity | 380,000 | 197,000 | 57,000 | 96,370 | 337,000 |
| Operating Cash Flow | $1,027,000 | $559,000 | $233,000 | $1,267,360 | $915,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -411,000 | -236,000 | -125,000 | -500,830 | -315,000 |
| Other Investing Activity | -20,000 | -7,000 | -1,000 | 166,670 | 182,000 |
| Investing Cash Flow | $-431,000 | $-243,000 | $-126,000 | $-334,160 | $-133,000 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | 0 | -248,490 | 0 |
| Other Financing Activity | -673,000 | -522,000 | -314,000 | -330,330 | -468,000 |
| Financing Cash Flow | $-673,000 | $-522,000 | $-314,000 | $-578,820 | $-468,000 |
| Exchange Rate Effect | 25,000 | 26,000 | 22,000 | 0 | -4,000 |
| Beginning Cash Position | 479,000 | 480,000 | 515,000 | 140,440 | 139,000 |
| End Cash Position | 427,000 | 300,000 | 330,000 | 494,820 | 449,000 |
| Net Cash Flow | $-52,000 | $-180,000 | $-185,000 | $354,370 | $310,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,027,000 | 559,000 | 233,000 | 1,267,360 | 915,000 |
| Free Cash Flow | 1,027,000 | 559,000 | 233,000 | 1,267,360 | 915,000 |